These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19229863)
41. Hyperoside protects primary rat cortical neurons from neurotoxicity induced by amyloid β-protein via the PI3K/Akt/Bad/Bcl(XL)-regulated mitochondrial apoptotic pathway. Zeng KW; Wang XM; Ko H; Kwon HC; Cha JW; Yang HO Eur J Pharmacol; 2011 Dec; 672(1-3):45-55. PubMed ID: 21978835 [TBL] [Abstract][Full Text] [Related]
42. Activation of Hif1α by the prolylhydroxylase inhibitor dimethyoxalyglycine decreases radiosensitivity. Ayrapetov MK; Xu C; Sun Y; Zhu K; Parmar K; D'Andrea AD; Price BD PLoS One; 2011; 6(10):e26064. PubMed ID: 22016813 [TBL] [Abstract][Full Text] [Related]
43. Concomitant inhibition of prolyl hydroxylases and ROCK initiates differentiation of mesenchymal stem cells and PC12 towards the neuronal lineage. Pacary E; Petit E; Bernaudin M Biochem Biophys Res Commun; 2008 Dec; 377(2):400-406. PubMed ID: 18848521 [TBL] [Abstract][Full Text] [Related]
44. Dimethyloxalylglycine (DMOG) and the Caspase Inhibitor "Ac-LETD-CHO" Protect Neuronal ND7/23 Cells of Gluocotoxicity. Mukhopadhyay D; Hammami M; Khalouf A; Shaikh YA; Mohammed AK; Hamad M; Salehi A; Taneera J Exp Clin Endocrinol Diabetes; 2021 Jun; 129(6):420-428. PubMed ID: 31185507 [TBL] [Abstract][Full Text] [Related]
45. Dimethyloxalylglycine may be enhance the capacity of neural-like cells in treatment of Alzheimer disease. Ghasemi Moravej F; Vahabian M; Soleimani Asl S Cell Biol Int; 2016 Jun; 40(6):619-20. PubMed ID: 27005959 [TBL] [Abstract][Full Text] [Related]
46. Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes. Stoehr A; Yang Y; Patel S; Evangelista AM; Aponte A; Wang G; Liu P; Boylston J; Kloner PH; Lin Y; Gucek M; Zhu J; Murphy E Cardiovasc Res; 2016 Jun; 110(3):346-58. PubMed ID: 27095734 [TBL] [Abstract][Full Text] [Related]
48. Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives. Cunliffe CJ; Franklin TJ; Hales NJ; Hill GB J Med Chem; 1992 Jul; 35(14):2652-8. PubMed ID: 1321909 [TBL] [Abstract][Full Text] [Related]
49. Differential role of prolyl hydroxylases on mitochondrial function of HL-1 cells in a model of iron deficiency. Kandilci HB; Şimşek G; Zirapli T; Çelebier M Mitochondrion; 2022 Mar; 63():51-56. PubMed ID: 35066139 [TBL] [Abstract][Full Text] [Related]
50. Approaches to the design of anti-fibrotic drugs. Franklin TJ; Hales NJ; Johnstone D; Morris WB; Cunliffe CJ; Millest AJ; Hill GB Biochem Soc Trans; 1991 Nov; 19(4):812-5. PubMed ID: 1665444 [No Abstract] [Full Text] [Related]
51. Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats. Liu XB; Wang JA; Ji XY; Yu SP; Wei L Stem Cell Res Ther; 2014 Sep; 5(5):111. PubMed ID: 25257482 [TBL] [Abstract][Full Text] [Related]
52. A novel effect of DMOG on cell metabolism: direct inhibition of mitochondrial function precedes HIF target gene expression. Zhdanov AV; Okkelman IA; Collins FW; Melgar S; Papkovsky DB Biochim Biophys Acta; 2015 Oct; 1847(10):1254-66. PubMed ID: 26143176 [TBL] [Abstract][Full Text] [Related]
54. Dimethyloxaloylglycine improves angiogenic activity of bone marrow stromal cells in the tissue-engineered bone. Ding H; Chen S; Song WQ; Gao YS; Guan JJ; Wang Y; Sun Y; Zhang CQ Int J Biol Sci; 2014; 10(7):746-56. PubMed ID: 25013382 [TBL] [Abstract][Full Text] [Related]
55. [Hypoxic preconditioning of stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction]. Maslov LN; Podoksenov IuK; Portnichenko AG; Naumova AV Vestn Ross Akad Med Nauk; 2013; (12):16-25. PubMed ID: 24741938 [TBL] [Abstract][Full Text] [Related]
57. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs. Liu H; Xue W; Ge G; Luo X; Li Y; Xiang H; Ding X; Tian P; Tian X Biochem Biophys Res Commun; 2010 Oct; 401(4):509-15. PubMed ID: 20869949 [TBL] [Abstract][Full Text] [Related]
58. Administration of AG490 decreases the senescence of umbilical cord-mesenchymal stem cells and promotes the cytotherapeutic effect in liver fibrosis. Jiang C; Chen H; Kang Y; He X; Huang J; Lu T; Sui X; Chen H; Xiao J; Zhang J; Zhang H; Zheng J; Yang Y; Yao J; Cai J; Zhang Y Cell Death Discov; 2023 Jul; 9(1):273. PubMed ID: 37507381 [TBL] [Abstract][Full Text] [Related]
59. Mesenchymal Stem Cells Pretreated with Collagen Promote Skin Wound-Healing. Kou Z; Li B; Aierken A; Tan N; Li C; Han M; Jing Y; Li N; Zhang S; Peng S; Zhao X; Hua J Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240027 [TBL] [Abstract][Full Text] [Related]
60. The Role of HIF-1α in Bone Regeneration: A New Direction and Challenge in Bone Tissue Engineering. You J; Liu M; Li M; Zhai S; Quni S; Zhang L; Liu X; Jia K; Zhang Y; Zhou Y Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]